Arlington Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,760
| Closed | -$58.4K | – | 353 |
|
|
2023
Q3 | $58.4K | Sell |
1,760
-8,323
| -83% | -$276K | 0.02% | 132 |
|
|
2023
Q2 | $370K | Sell |
10,083
-3,228
| -24% | -$118K | 0.06% | 101 |
|
|
2023
Q1 | $543K | Buy |
13,311
+4,825
| +57% | +$197K | 0.08% | 76 |
|
|
2022
Q4 | $435K | Sell |
8,486
-897
| -10% | -$46K | 0.07% | 68 |
|
|
2022
Q3 | $411K | Sell |
9,383
-124
| -1% | -$5.43K | 0.16% | 65 |
|
|
2022
Q2 | $498K | Hold |
9,507
| – | – | 0.17% | 66 |
|
|
2022
Q1 | $492K | Buy |
9,507
+124
| +1% | +$6.42K | 0.14% | 70 |
|
|
2021
Q4 | $554K | Buy |
9,383
+1,170
| +14% | +$69.1K | 0.15% | 64 |
|
|
2021
Q3 | $353K | Buy |
+8,213
| New | +$353K | 0.1% | 75 |
|
|
2020
Q1 | – | Sell |
-1,413
| Closed | -$53K | – | 354 |
|
|
2019
Q4 | $53K | Hold |
1,413
| – | – | 0.03% | 117 |
|
|
2019
Q3 | $48K | Sell |
1,413
-844
| -37% | -$28.7K | 0.03% | 104 |
|
|
2019
Q2 | $93K | Sell |
2,257
-214
| -9% | -$8.82K | 0.04% | 114 |
|
|
2019
Q1 | $100K | Buy |
2,471
+214
| +9% | +$8.66K | 0.07% | 100 |
|
|
2018
Q4 | $93K | Buy |
2,257
+887
| +65% | +$36.5K | 0.06% | 91 |
|
|
2018
Q3 | $57K | Buy |
1,370
+316
| +30% | +$13.1K | 0.04% | 121 |
|
|
2018
Q2 | $36K | Hold |
1,054
| – | – | 0.03% | 83 |
|
|
2018
Q1 | $35K | Buy |
+1,054
| New | +$35K | 0.03% | 86 |
|